AU5702698A - Polyprolyl inhibitors of cyclophilin - Google Patents
Polyprolyl inhibitors of cyclophilinInfo
- Publication number
- AU5702698A AU5702698A AU57026/98A AU5702698A AU5702698A AU 5702698 A AU5702698 A AU 5702698A AU 57026/98 A AU57026/98 A AU 57026/98A AU 5702698 A AU5702698 A AU 5702698A AU 5702698 A AU5702698 A AU 5702698A
- Authority
- AU
- Australia
- Prior art keywords
- polyprolyl
- cyclophilin
- inhibitors
- polyprolyl inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1021—Tetrapeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76190296A | 1996-12-09 | 1996-12-09 | |
US08761902 | 1996-12-09 | ||
PCT/US1997/023102 WO1998025950A1 (en) | 1996-12-09 | 1997-12-08 | Polyprolyl inhibitors of cyclophilin |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5702698A true AU5702698A (en) | 1998-07-03 |
Family
ID=25063558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU57026/98A Abandoned AU5702698A (en) | 1996-12-09 | 1997-12-08 | Polyprolyl inhibitors of cyclophilin |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0966479A4 (es) |
JP (1) | JP2001505920A (es) |
AR (1) | AR010744A1 (es) |
AU (1) | AU5702698A (es) |
CA (1) | CA2263828A1 (es) |
PA (1) | PA8442401A1 (es) |
WO (1) | WO1998025950A1 (es) |
ZA (1) | ZA9710989B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1098897B1 (en) | 1998-07-17 | 2004-06-09 | Agouron Pharmaceuticals, Inc. | Compounds, compositions, and methods for stimulating neuronal growth and elongation |
AU5606400A (en) | 1999-07-09 | 2001-01-30 | Ortho-Mcneil Pharmaceutical, Inc. | Neurotrophic tetrahydroisoquinolines and tetrahydrothienopyridines, and related compositions and methods |
HUP0202249A3 (en) | 1999-07-09 | 2003-01-28 | Ortho Mcneil Pharm Inc | Neurotrophic pyrrolidines and piperidines, compositions containing them and use of the compounds |
US6544976B1 (en) | 1999-07-09 | 2003-04-08 | Ortho-Mcneil Pharmaceutical, Inc. | Neurotrophic 2-azetidinecarboxylic acid derivatives, and related compositions and methods |
SK11452002A3 (sk) * | 2000-02-11 | 2003-03-04 | Vertex Pharmaceuticals Incorporated | Deriváty piperazínu a piperidínu na použitie pri liečení alebo prevencii poškodenia neurónov |
GB0030378D0 (en) | 2000-12-13 | 2001-01-24 | Cyclacel Ltd | Compound |
US6593362B2 (en) | 2001-05-21 | 2003-07-15 | Guilford Pharmaceuticals Inc. | Non-peptidic cyclophilin binding compounds and their use |
EP3164148A4 (en) | 2014-06-25 | 2017-12-13 | Cold Spring Harbor Laboratory | Methods and compositions for inhibiting growth and epithelial to mesenchymal transition (emt) in cancer cells |
SG11202010016QA (en) | 2018-04-10 | 2020-11-27 | Sanofi Aventis Deutschland | Lixisenatide synthesis with capping |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5023077A (en) * | 1989-01-24 | 1991-06-11 | Aphton Corporation | Immunogenic compositions and methods for the treatment and prevention of gastric and duodenal ulcer disease |
JP2782142B2 (ja) * | 1992-07-23 | 1998-07-30 | カルピス株式会社 | アンジオテンシン変換酵素阻害剤及びその製造法 |
IL106998A0 (en) * | 1992-09-17 | 1993-12-28 | Univ Florida | Brain-enhanced delivery of neuroactive peptides by sequential metabolism |
JP3089350B2 (ja) * | 1995-11-20 | 2000-09-18 | ギルフォード ファーマシューティカルズ インコーポレイテッド | シクロフィリンロタマーゼ活性の阻害剤 |
-
1997
- 1997-12-05 AR ARP970105727A patent/AR010744A1/es unknown
- 1997-12-05 PA PA19978442401A patent/PA8442401A1/es unknown
- 1997-12-08 ZA ZA9710989A patent/ZA9710989B/xx unknown
- 1997-12-08 CA CA002263828A patent/CA2263828A1/en not_active Abandoned
- 1997-12-08 JP JP52703798A patent/JP2001505920A/ja not_active Withdrawn
- 1997-12-08 EP EP97953231A patent/EP0966479A4/en not_active Withdrawn
- 1997-12-08 AU AU57026/98A patent/AU5702698A/en not_active Abandoned
- 1997-12-08 WO PCT/US1997/023102 patent/WO1998025950A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1998025950A1 (en) | 1998-06-18 |
EP0966479A4 (en) | 2004-12-08 |
ZA9710989B (en) | 1999-05-25 |
CA2263828A1 (en) | 1998-06-18 |
JP2001505920A (ja) | 2001-05-08 |
EP0966479A1 (en) | 1999-12-29 |
PA8442401A1 (es) | 2000-05-24 |
AR010744A1 (es) | 2000-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1301697A (en) | Tyrosin-derivate as alpha-v-integrin inhibitors | |
AU1271297A (en) | Inhibitor of ceramidase | |
AU4261697A (en) | Compounds and methods | |
AU3102397A (en) | Metalloprotease inhibitors | |
AU5901598A (en) | Compositions and methods of use for osteoclast inhibitory factors | |
AU5599598A (en) | Inhibitors of glycosyltransferases | |
AU3459897A (en) | Differentiation inhibitor | |
AU3673497A (en) | Detection of microbacteria | |
AU2277597A (en) | New inhibitors of sh2-mediated processes | |
AU5702698A (en) | Polyprolyl inhibitors of cyclophilin | |
AU1600597A (en) | Stabilisation of polyolefin-recyclates | |
AU3120297A (en) | Human phospholipase inhibitor | |
AU3118297A (en) | Sok-1 and methods of use | |
AU1013997A (en) | Amylase inhibitors | |
AU2445997A (en) | Telomerase inhibitors | |
AU3042697A (en) | Thrombin inhibitors | |
GB9502985D0 (en) | Enzyme inhibitors | |
AU6049796A (en) | Lysyloxidase inhibitors | |
AU4422897A (en) | Cross-dimerization of olefins | |
AU2908197A (en) | Thrombin inhibitors | |
AU5126298A (en) | Inhibition of crib-biting | |
AU4618197A (en) | Thrombin inhibitors | |
AU2545697A (en) | Novel uses of phospholipase c inhibitors | |
AUPO982097A0 (en) | Methods and compositions for use therein | |
AU2595297A (en) | Use of aminoalkylcarboxylic derivatives |